Pharmacokinetics and pharmacodynamics of intranasal and intramuscular administration of naloxone in working dogs administered fentanyl
Open Access
- 1 November 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 37 (6) , 2422-2428
Abstract
Background: Working dogs exposed to narcotics might require reversal in the field. Objective: To explore the pharmacokinetic and pharmacodynamic effects of naloxone administered intramuscularly (IM) or intranasally (IN) to reverse fentanyl sedation in working dogs. Animals: Ten healthy, working dogs aged 1.7 ± 1 year and weighing 26 ± 3 kg. Methods: In this randomized, controlled cross-over study dogs received either 4 mg of naloxone IN or IM 10 minutes after fentanyl (0.3 mg IV) administration. Sedation was assessed at baseline and 5 minutes after fentanyl administration, then at 5, 10, 15, 20, 25, 30, 60 and 120 minutes after reversal with naloxone. Blood samples for naloxone detection were obtained at 0, 5, 10, 30, 60 and 120 minutes. Pharmacokinetic parameters and sedation scores were compared between IM and IN naloxone groups. Results: There was a significant increase in sedation score from baseline (0.25 [−4 to 1] IM; 0 [−2 to 1] IN) after fentanyl administration (11 [5-12] IM; 9.25 [4-11] IN), followed by a significant reduction at 5 (0.5 [−0.5 to 1.5] IM; 1.25 [−1.5 to 4.5] IN) through 120 minutes (−0.5 [−2 to 1] IM; 0 [−4.5 to 1] IN) after reversal with naloxone. Route of administration had no significant effect on sedation score. Maximum plasma concentration was significantly lower after IN administration (11.7 [2.8-18.8] ng/mL IN, 36.7 [22.1-56.4] ng/mL IM, P < .001) but time to reach maximum plasma concentration was not significantly different from IM administration. Conclusion and Clinical Importance: Although IM administration resulted in higher naloxone plasma concentrations compared to IN, reversal of sedation was achieved via both routes after administration of therapeutic doses of fentanyl.Keywords
Funding Information
- U.S. Department of Homeland Security (HSHQDC-17-P-00112)
- U.S. Department of Homeland Security (HSHQDC‐17‐P‐00112)
This publication has 18 references indexed in Scilit:
- Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deathsThe American Journal of Emergency Medicine, 2015
- Emergency Medical Services Naloxone Access: A National Systematic Legal ReviewAcademic Emergency Medicine, 2014
- The history and pharmacology of fentanyl: relevance to a novel, long‐acting transdermal fentanyl solution newly approved for use in dogsJournal of Veterinary Pharmacology and Therapeutics, 2012
- Naloxone reversal of an overdose of a novel, long‐acting transdermal fentanyl solution in laboratory BeaglesJournal of Veterinary Pharmacology and Therapeutics, 2012
- RECOVER evidence and knowledge gap analysis on veterinary CPR. Part 7: Clinical guidelinesJournal of Veterinary Emergency and Critical Care, 2012
- Effects of acepromazine, hydromorphone, or an acepromazine-hydromorphone combination on the degree of sedation in clinically normal dogsJournal of the American Veterinary Medical Association, 2010
- Development of a canine nociceptive thermal escape modelJournal of Neuroscience Methods, 2007
- Opioid AnalgesicsVeterinary Clinics of North America: Small Animal Practice, 2000
- Fentanyl's Analgesic, Respiratory, and Cardiovascular Actions in Relation to Dose and Plasma Concentration in Unanesthetized DogsAnesthesiology, 1984
- Circulatory Pattern and Duration of Action of Naloxone in Dogs With and Without Opioid PretreatmentActa Anaesthesiologica Scandinavica, 1979